Abbott Laboratories · Change in Working Capital

Latest reported$653.00Mperiod endingJun 30, 2026

ABT Change in Working Capital (-$212.30M → $653.00M)

Annual change in working capital

High-resolution chart · PNG

ABT change in working capital history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories Change in Working Capital — Annual fiscal periods (USD)
Period ending	Change in Working Capital (USD)
Dec 31, 2025	-803,000,000
Dec 31, 2024	-9,217,000,000
Dec 31, 2023	-2,475,000,000
Dec 31, 2022	-1,519,000,000
Dec 31, 2021	-771,000,000
Dec 31, 2020	-892,000,000
Dec 31, 2019	-1,331,000,000
Dec 31, 2018	-148,000,000
Dec 31, 2017	1,915,000,000
Dec 31, 2016	-1,513,000,000
Dec 31, 2015	-156,000,000
Dec 31, 2014	-490,000,000
Dec 31, 2013	-1,237,000,000
Dec 31, 2012	-1,859,833,000
Dec 31, 2011	1,067,000
Dec 31, 2010	658,784,000
Dec 31, 2009	-341,382,000
Dec 31, 2008	-39,686,000
Dec 31, 2007	-1,063,365,000
Dec 31, 2006	-548,061,000
Dec 31, 2005	173,941,000
Dec 31, 2004	-484,919,000
Dec 31, 2003	-496,819,000
Dec 31, 2002	-30,276,000
Dec 31, 2001	-641,896,000
Dec 31, 2000	-445,197,000
Dec 31, 1999	-419,956,000
Dec 31, 1998	-461,195,000
Dec 31, 1997	-338,465,000
Dec 31, 1996	-239,861,000
Dec 31, 1995	-337,597,000
Dec 31, 1994	154,516,000
Dec 31, 1993	-2,055,000
Dec 31, 1992	-282,500,000
Dec 31, 1991	-61,800,000
Dec 31, 1990	-111,200,000
Dec 31, 1989	-212,300,000